These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 836501)

  • 1. Inhibition of solid tumors by nitrosoureas. 1. Lewis lung carcinoma.
    Montgomery JA; McCaleb GS; Johnston TP; Mayo JG; Laster WR
    J Med Chem; 1977 Feb; 20(2):291-5. PubMed ID: 836501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemistry and structure-activity studies of the nitrosoureas.
    Montgomery JA
    Cancer Treat Rep; 1976 Jun; 60(6):651-64. PubMed ID: 954007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative structure-activity relationships in anticancer agents. Activity of selected nitrosoureas against a solid tumor, the Lewis lung carcinoma.
    Montgomery JA; Mayo JG
    J Med Chem; 1974 May; 17(5):477-80. PubMed ID: 4830248
    [No Abstract]   [Full Text] [Related]  

  • 4. 1,3-bis(2-chloroethyl)-1-nitrosourea (bcnu) and other nitrosoureas in cancer treatment: a review.
    Carter SK; Schabel FM; Broder LE; Johnston TP
    Adv Cancer Res; 1972; 16():273-332. PubMed ID: 4563045
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea on experimental tumors.
    Akaike Y; Arai Y; Taguchi H; Satoh H
    Gan; 1982 Jun; 73(3):480-7. PubMed ID: 7129012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitrosoureas: a review of experimental antitumor activity.
    Schabel FM
    Cancer Treat Rep; 1976 Jun; 60(6):665-98. PubMed ID: 782694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic potentiation of nitrosoureas using chlorpromazine and caffeine in the treatment of murine tumors.
    Rose WC; Trader MW; Dykes DJ; Laster WR; Schabel FM
    Cancer Treat Rep; 1978 Dec; 62(12):2085-93. PubMed ID: 751716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor activity and toxicity of methyl 6-[3-(2-chloroethyl)- 3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside in experimental animals.
    Fujimoto S; Tashiro T; Ogawa M
    Gan; 1984 Oct; 75(10):937-46. PubMed ID: 6510639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologic activity of MCNU: a new antitumor agent.
    Sekido S; Ninomiya K; Iwasaki M
    Cancer Treat Rep; 1979 Jun; 63(6):961-70. PubMed ID: 466655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor effects of GANU and other nitrosourea derivatives against transplantable leukemias and solid tumors in mice.
    Sava G; Giraldi T
    Cancer Chemother Pharmacol; 1983; 10(3):167-9. PubMed ID: 6222844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytostatic action of two nitrosoureas derived from cysteamine.
    Bourut C; Chenu E; Godenèche D; Madelmont JC; Maral R; Mathé G; Meyniel G
    Br J Pharmacol; 1986 Nov; 89(3):539-46. PubMed ID: 3801787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Success and failure in the treatment of solid tumors. 3. "Cure" of metastatic Lewis lung carcinoma with methyl-CCNU (NSC-95442) and surgery-chemotherapy.
    Mayo JG; Laster WR; Andrews CM; Schabel FM
    Cancer Chemother Rep; 1972 Apr; 56(2):183-95. PubMed ID: 5043226
    [No Abstract]   [Full Text] [Related]  

  • 13. Potentiation of therapeutic effects of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride by 6-thioguanine in mouse tumor systems: comparison with other antimetabolites.
    Fujimoto S; Ogawa M; Hoshino A
    Gan; 1980 Feb; 71(1):60-72. PubMed ID: 6929770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biologic characterization of the subcutaneously implanted Lewis lung tumor.
    Mayo JG
    Cancer Chemother Rep 2; 1972 Nov; 3(1):325-30. PubMed ID: 4660735
    [No Abstract]   [Full Text] [Related]  

  • 15. Antitumor structure-activity relations. Nitrosoureas vs. L-1210 leukemia.
    Hansch C; Leo A; Schmidt C; Jow PY; Montgomery JA
    J Med Chem; 1980 Oct; 23(10):1095-101. PubMed ID: 7420354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic and diabetogenic potential of two newly synthesized nitrosoureido sugars.
    Bernacki RJ; Wilson GL; Mossman BT; Angelino N; Kanter PM; Korytnyk W
    Cancer Res; 1985 Feb; 45(2):695-702. PubMed ID: 3881170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationships: nitrosoureas.
    Johnston TP
    Cancer Chemother Rep 3; 1972 May; 3(1):50-1. PubMed ID: 5065660
    [No Abstract]   [Full Text] [Related]  

  • 18. Antitumor activity of amidoximes (hydroxyurea analogs) in murine tumor systems.
    Flora KP; van't Riet B; Wampler GL
    Cancer Res; 1978 May; 38(5):1291-5. PubMed ID: 639062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of antitumor effect of cyclophosphamide by thaliblastine in Lewis lung carcinoma and L1210 leukemia in mice.
    Stoychkov JN; Miloushev AS
    Biomedicine; 1980 Apr; 33(2):42-4. PubMed ID: 6447522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contributions of nitrosoureas to cancer treatment.
    Mitchell EP; Schein PS
    Cancer Treat Rep; 1986 Jan; 70(1):31-41. PubMed ID: 3002621
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.